Indianapolis, IN, United States of America

Nancy E Beerman

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nancy E Beerman

Introduction

Nancy E Beerman is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies. Her work has implications for various applications in microbiology and genetic engineering.

Latest Patents

Nancy E Beerman holds 1 patent for her invention titled "Multifunctional, cloning vectors for use in Streptomyces, Bacillus, and E. coli." This patent discloses multifunctional recombinant DNA cloning vectors that are designed for use in these bacterial species. The invention also includes transformants of the aforementioned vectors, showcasing her innovative approach to genetic manipulation.

Career Highlights

Nancy is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly allows her to apply her expertise in biotechnology and contribute to the development of new therapeutic solutions. Her work is instrumental in advancing the company's research initiatives.

Collaborations

Throughout her career, Nancy has collaborated with esteemed colleagues such as Jeffrey T Fayerman and Steven Kovacevic. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Nancy E Beerman's contributions to biotechnology through her patent and work at Eli Lilly and Company highlight her role as a pioneering inventor. Her innovative spirit continues to drive advancements in the field, making a lasting impact on science and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…